Literature DB >> 28922977

Rebuttal to Smith and Janssen (Thyroid 2017;27:746-747. DOI: 10.1089/thy.2017.0281).

Susanne Neumann1, Marvin C Gershengorn1.   

Abstract

Year:  2017        PMID： 28922977      PMCID： PMC5695741          DOI： 10.1089/thy.2017.0472

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  6 in total

1.  TSHR/IGF-1R Cross-Talk, Not IGF-1R Stimulating Antibodies, Mediates Graves' Ophthalmopathy Pathogenesis.

Authors:  Christine C Krieger; Susanne Neumann; Bernice Marcus-Samuels; Marvin C Gershengorn
Journal:  Thyroid       Date:  2017-03-27       Impact factor: 6.568

2.  Inhibiting thyrotropin/insulin-like growth factor 1 receptor crosstalk to treat Graves' ophthalmopathy: studies in orbital fibroblasts in vitro.

Authors:  Robert F Place; Christine C Krieger; Susanne Neumann; Marvin C Gershengorn
Journal:  Br J Pharmacol       Date:  2017-01-27       Impact factor: 8.739

3.  Response to Krieger et al. re: "TSHR/IGF-1R Cross-Talk, Not IGF-1R Stimulating Antibodies, Mediates Graves' Ophthalmopathy Pathogenesis" (Thyroid 2017;27:746-747).

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Thyroid       Date:  2017-09-28       Impact factor: 6.568

4.  Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves' disease immunoglobins.

Authors:  Christine C Krieger; Susanne Neumann; Robert F Place; Bernice Marcus-Samuels; Marvin C Gershengorn
Journal:  J Clin Endocrinol Metab       Date:  2014-12-08       Impact factor: 5.958

5.  TSH/IGF-1 Receptor Cross Talk in Graves' Ophthalmopathy Pathogenesis.

Authors:  Christine C Krieger; Robert F Place; Carmine Bevilacqua; Bernice Marcus-Samuels; Brent S Abel; Monica C Skarulis; George J Kahaly; Susanne Neumann; Marvin C Gershengorn
Journal:  J Clin Endocrinol Metab       Date:  2016-04-04       Impact factor: 5.958

Review 6.  Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Front Endocrinol (Lausanne)       Date:  2017-01-03       Impact factor: 5.555
  6 in total
  2 in total

1.  Evidence That Graves' Ophthalmopathy Immunoglobulins Do Not Directly Activate IGF-1 Receptors.

Authors:  Bernice Marcus-Samuels; Christine C Krieger; Alisa Boutin; George J Kahaly; Susanne Neumann; Marvin C Gershengorn
Journal:  Thyroid       Date:  2018-04-30       Impact factor: 6.568

2.  It takes two to Tango: IGF-I and TSH Receptors in Thyroid Eye Disease.

Authors:  Leonard Girnita; Terry J Smith; Joseph A M J L Janssen
Journal:  J Clin Endocrinol Metab       Date:  2022-02-15       Impact factor: 6.134
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.